Sanofi Consumer Healthcare India Peer Comparison

Sanofi Consumer Healthcare India Ltd. is lagging significantly behind its peers in key financial metrics including profitability, efficiency, and growth. With no revenue growth or profitability indicators, it is classified as financially weak, while its peers exhibit stronger financial health and growth potential.

• • Sanofi shows no revenue growth, EPS, or profitability indicators.
• • Sun Pharma and Cipla are standout performers in terms of growth and returns.
• • Sanofi's high PE ratio indicates it may be overvalued given its lack of performance.

• • Cipla Ltd.: Strong revenue growth (13.28% YoY) and attractive PE ratio (23.73) with solid profitability metrics.
• • Sun Pharmaceutical Industries Ltd.: Highest EPS (45.55), strong revenue growth (8.42% YoY), and robust ROE (16.13%).
• • Dr. Reddy's Laboratories Ltd.: Solid profitability metrics with high ROE (21.76%) and revenue growth (16.54% YoY).